KCT0008348已完成Unknown
Clinical study for the effect of prebiotics in patients with breast cancer
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20(Year) 至 80(Year)（—）
- 性别
- Female
入选标准
- •? A person who agreed to participate in this study and signed a written consent form
- •? Among breast cancer patients aged 20 years or older, those who have completed both chemotherapy and radiotherapy after surgery
排除标准
- •? If participated person is diagnosed with the following diseases
- •Liver dysfunction or hepatobiliary disease
- •renal dysfunction
- •Previous history of cancer other than breast cancer
- •? Those who have taken or administered antibiotics within the last 1 month
- •? A person who has continuously consumed food (including health functional food) that may affect intestinal health within the past month
- •: Probiotics (lactic acid bacteria, etc.), prebiotics (dietary fiber, fructooligosaccharides, etc.)
- •? Those who have hypersensitivity to prebiotics or ingredients or have experienced severe food allergic reactions
- •? Those who have participated in other clinical studies within the last 1 month
- •? Those who abuse alcohol/drugs or are suspected of abuse
- •? People unable to communicate
- •? People with other diseases that the researcher deems inappropriate to participate in this study
研究者
相似试验
招募中
2 期
Effects of probiotics on the prevalence of ventilator-associated pneumoniaVentilator-associated pneumonia.Ventilator associated pneumoniaJ95.851IRCT20190325043107N18Tabriz University of Medical Sciences150
已完成
不适用
Effect of Prebiotic in Clinical and Paraclinical Parameters of Poly Cystic Ovarian Syndrom (PCOS)clinical parameters.Polycystic ovarian syndromeIRCT2016062810324N33Vice chancellor for research, Tabriz University of Medical Sciences62
已完成
4 期
use of probiotics in gum healthCTRI/2017/10/010213Kumari Upasana40
进行中（未招募）
2 期
Evaluation of effect of probiotic in the treatment of cancer soresRBR-4w2jc2niversidade Federal de São Paulo
招募中
不适用
PRIMAL Clinical Study: Efficacy of probiotics to prevent gut dysbiosis in very preterm infants (VPIs) and moderate preterm infants of 28+0 – 32+6 weeks of gestation: A randomized, placebo-controlled double-blind studyK63.8Other specified diseases of intestineDRKS00013197niversitätsklinikum Schleswig-Holstein654